On October 8, 2026 ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, reported that Dr. Patrick Soon-Shiong, its Founder, Executive Chairman and Global Chief Scientific and Medical Officer, will participate virtually in a fireside chat at the Piper Sandler Virtual Oncology Symposium, taking place October 15-16, 2026.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details of the event are provided below:
Piper Sandler Virtual Oncology Symposium – Fireside Chat
Participant: Patrick Soon-Shiong, M.D., Founder, Executive Chairman and Global Chief Scientific and Medical Officer, ImmunityBio
Moderator: Ted Tenthoff, Managing Director and Senior Research Analyst, Piper Sandler
Date: Friday, October 16, 2026
Time: 1:00-1:25 p.m. ET
Please contact Piper Sandler for information about attending the symposium and accessing session recordings.
"We welcome the opportunity to join Piper Sandler and the investment community to discuss ImmunityBio’s progress and our vision for transforming cancer care by activating the body’s innate and adaptive immune systems," said Patrick Soon-Shiong, M.D., Founder, Executive Chairman and Global Chief Scientific and Medical Officer of ImmunityBio. "With the continued advancement of ANKTIVA (nogapendekin alfa inbakicept-pmln) and our broader immunotherapy pipeline, we remain focused on translating innovative science into durable treatment options for patients with difficult-to-treat diseases."
(Press release, ImmunityBio, OCT 8, 2026, View Source [SID1234673282])